Navigation Links
Peregrine Pharmaceuticals Receives Approval to Begin New Phase II Trial of Bavituximab in Patients With Metastatic Breast Cancer
Date:11/16/2007

iew in India. Bavituximab is in clinical trials in the U.S. in patients with advanced solid tumors and in patients co-infected with HCV and HIV.

About Peregrine Pharmaceuticals

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company with a portfolio of innovative product candidates in clinical trials for the treatment of cancer and hepatitis C virus (HCV) infection. The company is pursuing three separate clinical programs in cancer and HCV infection in the U.S. and India with its lead product candidates bavituximab and Cotara(R). Peregrine also has in-house manufacturing capabilities through its wholly owned subsidiary Avid Bioservices, Inc. (http://www.avidbio.com), which provides development and bio-manufacturing services for both Peregrine and outside customers. Additional information about Peregrine can be found at http://www.peregrineinc.com.

Safe Harbor Statement: Statements in this press release which are not purely historical, including statements regarding Peregrine Pharmaceuticals' intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including, but not limited to the risk that the company will experience delays or difficulties in enrolling patients in the study, and the risk that the results from this trial will not be consistent with the results of prior trials or preclinical studies. It is important to note that the company's actual results could differ materially from those in any such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, uncertainties associated with completing preclinical and clinical trials for our technologies; the e
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Positive Results From Peregrine Pharmaceuticals Bavituximab Phase l HCV Trial Presented at AASLD Meeting
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
7. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
8. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
9. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
10. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...wire-USNewswire/ -- Today, the House of Representa..., Smith, Ellsworth and Lipinski amendment to the "...). The amendment maintains the current policy of p...efits packages that include abortion. It clarifies...ility credits and those who do not, can with their...
(Date:11/8/2009)...wire-USNewswire/ -- Pharmaceutical Research and Ma...nt Ken Johnson released the following statement re...We are disappointed, but not surprised by today,s ...rking Americans as well as nearly half of the memb... against the bill. ,, "While well intentioned, ...
(Date:11/8/2009)...o Sides With Working Families vs. Insurance Compan...ewswire/ -- On the heels of an historic late night...balanced health care reform bill, the Pennsylvania....S. representatives voted on HR 3962, the Affordab...tion, which passed Saturday evening by a vote of 2...
(Date:11/7/2009)...ewswire-USNewswire/ -- Speaker Nancy Pelosi spoke... the Affordable Health Care for America Act. The ... Below are the Speaker,s remarks. ,, "Madam Sp...t for our nation and for American families. For n...cal philosophy -- as far back as Teddy Roosevelt -...
(Date:11/7/2009)...e/ -- Calling this a "defining moment" for the Ame... J. James Rohack, M.D., today addressed medical st...dical specialty societies at the opening of the AM...h system reform will top the agenda. ,, (Logo: ...LOGO ) ,, "Over the next 72 hours, this AMA H...
Breaking Medicine News(10 mins):Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 2Health News:PhRMA Statement on House Passage of Health Care Reform Bill 3Health News:Robert Brady (D-PA-1), Chaka Fattah (D-PA-2), Kathy Dahlkemper (D-PA-3), Joe Sestak (D-PA-7), Patrick Murphy (D-PA-8), Christopher Carney (D-PA-10), John Murtha (D-PA-12), Paul Kanjorski (D-PA-11), Allyson Schwartz (D-PA-13), Mike Doyle (D-PA-14) Ge 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 2Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 3Health News:Pelosi: Health Legislation Founded on Key Principles for a Healthier America: Innovation, Competition and Prevention 4Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
..., Israel, May 13 Lumenis Inc., a global,developer...d radiofrequency,devices for surgical, aesthetic, ...aunch of a Holmium Laser Enucleation of the Prosta...e of,clinical evidence suggests that HoLEP provide...
... proceeds despite non-compliance with California E...(CEQA)., LOS ANGELES, May 12 Providence Holy Cro...e planned expansion of its,Holy Cross Medical Cent...y held today appears to be an attempt to create,"f...
..., May 12 /PRNewswire-FirstCall/ - Med-Emerg Intern...revenue from continuing operations,for the three m...red to,$4.8 million for the same period in 2007 (a...ved to $179K,from a loss of ($106K) in 2007. The i...
..., Calif., May 12 (Nasdaq: WHRT, TSX:,WHT) World H...") announced,that the Toronto Stock Exchange ("TSX...g the eligibility for continued listing on the TSX...and,operating results, more specifically whether t...
...NT, Calif., May 12 Keck Graduate Institute (KGI),...t ceremony will feature,the graduation of KGI,s fi..., and the unveiling of KGI,s first donated artwork...ice president for academic affairs, dean of facult...
...E, N.Y., May 12 Fairbank Farms, a national,ground...elected ground beef,products produced at its Ashvi..., Shaw,s, BJ,s, and Wilson Farms retail outlets an.../13/08, 05/15/08, or a,"Julian date 124" on the pa...
Other Medicine News:Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 2Health News:Lumenis Launches HoLEP Preceptor Program at American Urology Association 2008 Annual Meeting 3Health News:Providence Holy Cross Medical Center Ignores Community, Environmental Concerns With Planned Expansion of Mission Hills Facility 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 2Health News:Med-Emerg International Inc. reports improved income from continuing operations 3Health News:WorldHeart Notified of TSX Delisting Review 2Health News:KGI 2008 Commencement Features First PhD Graduate, Biotech Painting 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2
(Date:11/6/2009)..., Nov. 6 Philips Respironics appla... and Prevention (CDC) to raise awareness about an ...ufficiency. The CDC,s release of the first-ever go...es in sleeplessness is a milestone in quantifying ...g-time educator, industry leader and sleep therapy...
(Date:11/6/2009)...E PARK, N.C., Nov. 6 Chimerix, Inc...ailable antiviral therapeutics to address life-thr...pment of the company,s lead antiviral compound, CM...he Global Health Security Initiative (GHSI). CMX0...oped for the treatment of smallpox, as well as oth...
(Date:11/6/2009)... Caraco Pharmaceutical La...etorolac tromethamine ophthalmic solution, 0.5% fo... Administration (FDA) for Sun Pharma,s Abbreviated...74; opthalmic solution on the first day following ...herapeutically equivalent to Acular® Ophthalm...
Breaking Medicine Technology:Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution 2Blood Sugar Spikes Send Testosterone Levels Down 48816 1Blood Sugar Spikes Send Testosterone Levels Down 48816 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 1Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 2Lloydspharmacy Reveals Hayfever Misery to Hit One in Two People by 2060 48811 3Researchers describe implausible chemistry that produces herbicidal compound 8817 1Researchers describe implausible chemistry that produces herbicidal compound 8817 2
...,s Recombinant Protective Antigen Anthrax Vaccine ...gen,s Adjuvant, SCOTTSDALE, Ariz., Aug. 7 Immune... BioSciences Holdings, Inc.,(OTC Bulletin Board: I...Transfer Agreement (MTA) with VaxGen Inc. (Pink Sh...gen will receive the pharmaceutically active,ingre...
... for Antibiotics Eliminated in 87 Percent of Patie...s -, PRINCETON, N.J., Aug. 7 DEFLUX(R) (non-anim...r the treatment of,vesicoureteral reflux (VUR) in ...ry tract infections (UTIs) in children with VUR by...July issue of the Journal of,Laparoendoscopic & Ad...
Other Medicine Technology:ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 2ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 3ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc. 4DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 2DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 3DEFLUX(R) Significantly Reduces Urinary Tract Infections in Children With Vesicoureteral Reflux 4
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
...national reference laboratory and a worldwide lead...nt. ARUP offers an extensive test menu of highly c...atomic pathology. Owned by the University of Utah,... of the nation's university teaching hospitals and...
Medicine Products: